Author:
Ahmad F,McLeod D T,Croughan M J,Calder M A
Abstract
Fifty-four clinical isolates of Branhamella catarrhalis from patients with bronchopulmonary infections were studied. The MICs for 50 and 90% of the isolates and the geometric mean MICs were determined for 11 antimicrobial agents. All the strains were resistant to trimethoprim but were susceptible to clavulanate-potentiated amoxicillin (Augmentin; Beecham Research Laboratories, London), chloramphenicol, co-trimoxazole, erythromycin, cefotaxime, and cefuroxime. Beta-lactamase-negative strains were uniformly susceptible to penicillin and ampicillin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference18 articles.
1. Barry A. L. 1976. Antimicrobic susceptibility test: principles and practices. Lea & Febiger Philadelphia.
2. Branhamella catarrhalis: antibiotic susceptibility and a lactamase production;Brorson J. E.;J. Antimicrob. Chemother.,1981
3. Darling W. M. 1982. Branhamella catarrhalis. Lancet i:1244.
4. Davies B. I. and F. P. V. Maesen. 1983. The diagnosis and treatment of respiratory infections p. 132-147. In W. Brumfitt and J. M. T. Hamilton-Miller (ed.) A clinical approach to progress in infectious diseases. Oxford University Press Oxford England.
5. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification;Doern G. V.;J. Clin. Microbiol.,1980
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献